Zomedica (ZOM) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 10, 2026, to be held virtually, with shareholders able to vote and ask questions online.

• Key matters include election of eight directors, ratification of auditor, advisory vote on executive compensation, and amendment to by-laws regarding quorum for adjourned meetings.

• Record date for voting is April 21, 2026, with 979,949,668 outstanding common shares eligible.

• Board recommends voting FOR all proposals.

Voting matters and shareholder proposals

• Proposals: election of eight directors, ratification of Grant Thornton LLP as auditor for 2026, advisory say-on-pay vote, and amendment to by-laws on quorum for adjourned meetings.

• Shareholders may submit proposals for the 2027 meeting by December 29, 2026, and director nominations by March 12, 2027.

• Board recommends FOR all proposals.

Board of directors and corporate governance

• Board consists of eight directors, seven of whom are independent; CEO is not independent.

• Board met five times in 2025; all directors attended at least 75% of meetings.

• Three standing committees: Audit, Compensation, and Nominating and Corporate Governance, all composed entirely of independent directors.

• Chairman and CEO roles are separated.

• Board uses an informal process for director nominations and annual effectiveness assessments.